Case Comprehensive Cancer Center

President Eric W. Kaler and Provost Ben Vinson III announced today that they have named Stan Gerson as the medical school’s dean and the university’s senior vice president for medical affairs. His appointment begins Oct. 1. “We are delighted that Stan will continue to provide the exceptional leader...

Agreement Offers Additional Collaboration Opportunities between Organizations and across Northeast Ohio CLEVELAND, February 1, 2021 —Case Western Reserve University (CWRU) and University Hospitals (UH) have extended their affiliation through 2031 in an amendment that expands opportunities for colla...

The Cancer Center Seminar Series will kick off Friday, Sept. 10, at noon in Wolstein Research Building Auditorium (1-413). Partha Roy, associate professor of bioengineering and pathology at the University of Pittsburgh, will present “Targeting actin-regulatory protein in clear cell renal cancer.” T...

NCI-designated cancer centers, AACI members and other cancer centers and medical groups endorse HPV vaccination and cancer screening to eliminate cancers caused by the virus. The Case Comprehensive Cancer Center - a partnership of Case Western Reserve University, Cleveland Clinic and University Hos...

Jianjun Zhao, MD, PhD, has received a five-year, nearly $2.6 million grant from the National Cancer Institute, part of the National Institutes of Health, to investigate a new approach for treating chemotherapy-associated kidney damage. In study results published last year, Dr. Zhao and his team fou...

The Affordable Cancer Technology (ACT 2021) Conference is a global oncology virtual event open to the public for the first time Sept. 23–24. The focus will be the intersection of technological innovation, cancer research, and global disparities, and it will bring together researchers, public health ...

The U.S. Patent and Trademark Office has issued the first U.S. patent for a novel ovarian cancer vaccine technology developed by Cleveland Clinic researchers Vincent K. Tuohy, PhD, Suparna Mazumder, PhD, and Justin M. Johnson. The technology is licensed worldwide by Anixa Biosciences, Inc., a biotec...

​Scientists in Anant Madabhushi's lab have used artificial intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment—and which can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer. The key t...

Charis Eng, MD, PhD and Vinod Labhasetwar, PhD were recently selected to receive July 2021 Cleveland Clinic Caregiver Catalyst Grants. The Caregiver Catalyst Grants program pools the gifts from thousands of generous Cleveland Clinic donors into a fund allocated to support caregivers’ innovative idea...

Anant Madabhushi, PhD, director of the Center for Computational Imaging and Personalized Diagnostics and member of the Cancer Imaging Program of the Case Comprehensive Cancer Center, was recognized by The Pathologist’s Power List for the third consecutive year. This list celebrates 100 influential f...